Drug Shortage Report for PHENYLEPHRINE HYDROCHLORIDE INJECTION USP

Last updated on 2023-02-22 History
Report ID 181836
Drug Identification Number 02504545
Brand name PHENYLEPHRINE HYDROCHLORIDE INJECTION USP
Common or Proper name PHENYLEPHRINE HYDROCHLORIDE INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) PHENYLEPHRINE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 25 X 1 ML VIALS
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-01-20
Estimated end date 2023-02-28
Actual end date 2023-02-21
Shortage status Resolved
Updated date 2023-02-22
Company comments Limited inventory remaining at McKesson.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2023-02-22 English Compare
v5 2023-02-21 French Compare
v4 2023-02-21 English Compare
v3 2023-01-21 English Compare
v2 2023-01-19 French Compare
v1 2023-01-19 English Compare

Showing 1 to 6 of 6